Editorial: NSAIDs Pharmacogenomics
Guardado en:
Autores principales: | José A. G. Agúndez, Christine Formea, Andrea Gaedigk, Elena García-Martín, Li Gong, Tilo Grosser, Craig R. Lee, Katherine N. Theken |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0c2925f6a2994ecd9cf74f9d68333cd1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Anti-platelet drugs, pharmacogenomics and stent thrombosis: What’s new?
por: John Benjamin
Publicado: (2017) -
Monitoring Tacrolimus Concentrations in Whole Blood and Peripheral Blood Mononuclear Cells: Inter- and Intra-Patient Variability in a Cohort of Pediatric Patients
por: Amedeo De Nicolò, et al.
Publicado: (2021) -
Pharmacogenomics and Personalized Medicine in Type 2 Diabetes Mellitus: Potential Implications for Clinical Practice
por: Venkatachalapathy P, et al.
Publicado: (2021) -
Comparison of the Endoscopic Picture in Case of Complications of the upper Gastrointestinal Tract Caused by the Use of Antithrombotic Agents and Non-Steroidal Anti-Inflammatory Drugs
por: E. V. Moroz, et al.
Publicado: (2019) -
Mechanisms and the clinical relevance of complex drug–drug interactions
por: Roberts AG, et al.
Publicado: (2018)